Recent News

PPI Lawsuits: What’s Next?

The pharmaceutical liability attorneys at The Law Offices of Peter Angelos provide information regarding the risks related to proton pump inhibitors and the lawsuits filed by PPI consumers. Proton pump inhibitors (PPI) are used to treat a number of common abdominal conditions such as gastroesophageal reflux disease, stomach and duodenal ulcers, heartburn and erosive esophagitis….

Read More...

Jury Awards $70 Million to Victim of Talcum Powder

On October 27, 2016, a jury awarded a California woman more than $70 million in a lawsuit filed against talcum powder manufacturer Johnson & Johnson. This decision brings the total awards for three ovarian cancer victims in talcum powder lawsuits in 2016 to nearly $200 million.  Nearly 2,000 additional suits have been filed claiming primarily…

Read More...

Families Claim that Manufacturer Should Have Warned of Zofran Risks

The FDA approved Zofran, an antiemetic medication manufactured by GlaxoSmithKline (GSK) to prevent nausea and vomiting caused by cancer chemo therapy, radiation therapy, and surgery. Although Zofran was approved for distribution only for chemotherapy and radiation patients, GSK promoted the drug as an effective means to fight the same symptoms in pregnant women. Over the…

Read More...